Infeld; Martin Howard

Patent Applications and Registrations

Patent applications and USPTO patent grants for Infeld; Martin Howard.The latest application filed is for "novel pharmaceutical dosage forms comprising valganciclovir hydrochloride".

Company Profile

1.6.13

Infeld; Martin Howard - Upper Montclair NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pharmaceutical dosage forms comprising valganciclovir hydrochloride Grant 11,185,588 - Bachynsky , et al. November 30, 2	2021-11-30
Novel Pharmaceutical Dosage Forms Comprising Valganciclovir Hydrochloride App 20190117775 - Bachynsky; Maria Oksana ; et al.	2019-04-25
Novel Pharmaceutical Dosage Forms Comprising Valganciclovir Hydrochloride App 20180153998 - Bachynsky; Maria Oksana ; et al.	2018-06-07
Novel Pharmaceutical Dosage Forms Comprising Valganciclovir Hydrochloride App 20170266286 - Bachynsky; Maria Oksana ; et al.	2017-09-21
Pharmaceutical dosage forms comprising valganciclovir hydrochloride Grant 9,642,911 - Bachynsky , et al. May 9, 2	2017-05-09
Solid pharmaceutical dosage forms comprising bisphosphonates and modified amino acid carriers Grant 9,370,492 - Ahmed , et al. June 21, 2	2016-06-21
Novel Pharmaceutical Dosage Forms Comprising Valganciclovir Hydrochloride App 20150057296 - Bachynsky; Maria Oksana ; et al.	2015-02-26
Capecitabine Rapidly Disintegrating Tablets App 20150044287 - Bachynsky; Maria Oksana ; et al.	2015-02-12
Pharmaceutical dosage forms comprising valganciclovir hydrochloride Grant 8,889,109 - Bachynsky , et al. November 18, 2	2014-11-18
Novel Pharmaceutical Dosage Forms Comprising Valganciclovir Hydrochloride App 20130150382 - Bachynsky; Maria Oksana ; et al.	2013-06-13
Solid Pharmaceutical Dosage Forms Comprising Bisphosphonates And Modified Amino Acid Carriers App 20090281064 - Ahmed; Hashim ; et al.	2009-11-12
Saquinavir Mesylate Oral Dosage Form App 20090054481 - Albano; Antonio A. ; et al.	2009-02-26
Novel pharmaceutical dosage forms comprising valganciclovir hydrochloride App 20080146591 - Bachynsky; Maria Oksana ; et al.	2008-06-19
Capecitabine Rapidly Disintegrating Tablets App 20080085310 - Bachynsky; Maria Oksana ; et al.	2008-04-10
Solid pharmaceutical dosage forms comprising bisphosphonates and modified amino acid carriers App 20070049557 - Ahmed; Hashim ; et al.	2007-03-01
High dose solid unit oral pharmaceutical dosage form of amorphous nelfinavir mesylate and process for making same Grant 7,014,866 - Infeld , et al. March 21, 2	2006-03-21
Saquinavir mesylate oral dosage form App 20050009811 - Albano, Antonio A. ; et al.	2005-01-13
High dose solid unit oral pharmaceutical dosage form of amorphous nelfinavir mesylate and process for making same App 20030021840 - Infeld, Martin Howard ; et al.	2003-01-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.